LiteVax develop and exploit unique adjuvant platforms of fully synthetic compounds with distinct immunomodulatory profiles. Carbohydrates derivatives open opportunities for single-shot vaccines while heteropolymers are highly effective for booster immunization and mucosal application. These molecules are developed exclusively for its use as vaccine adjuvant and are the outcome of extensive optimization of efficacy/toxicity-ratio in large, non-rodent species.
